Position in PRGO
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$16,382,624
+$536,695 QoQ
Shares Held
1,525,384
+34.0% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sound Income Strategies, LLC holds $25,315,813 across 23 Drug Manufacturers - Specialty & Generic names. PRGO ranks #1 (64.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
This page
|
1,525,384 | $16,382,624 | |
| 2 | VTRS |
Viatris Inc
|
647,279 | $8,744,739 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,517 | $45,692 | |
| 4 | HLN |
Haleon plc
|
2,733 | $27,357 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,286 | $23,816 | |
| 6 | ZTS |
Zoetis Inc.
|
201 | $23,760 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
287 | $14,835 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
133 | $10,227 |
All Filings in PRGO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,382,624 | 1,525,384 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $15,845,929 | 1,138,357 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $15,983,869 | 717,731 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $14,133,918 | 528,964 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $13,966,051 | 498,076 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $12,413,070 | 482,811 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $9,846,322 | 375,384 | Shares | Sole | 2024-10-10 | |
| No filing history on record for this holder in this stock. | ||||||